According to Evoke Pharma
's latest financial reports the company has a price-to-book ratio of 1.11.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | -1.36 | -162.06% |
2022-12-31 | 2.19 | -56.58% |
2021-12-31 | 5.05 | -123.85% |
2020-12-31 | -21.2 | -334.42% |
2019-12-31 | 9.04 | -15.85% |
2018-12-31 | 10.7 | -33.25% |
2017-12-31 | 16.1 | 144.2% |
2016-12-31 | 6.59 | -3.97% |
2015-12-31 | 6.86 | 74.77% |
2014-12-31 | 3.92 | 83.03% |
2013-12-31 | 2.14 | |
2012-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ANI Pharmaceuticals ANIP | 2.79 | 152.46% | ๐บ๐ธ USA |
Amphastar Pharmaceuticals AMPH | 3.07 | 177.42% | ๐บ๐ธ USA |
Ironwood Pharmaceuticals
IRWD | -2.91 | -363.74% | ๐บ๐ธ USA |